Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jun 15;203(12):1449-1451.
doi: 10.1164/rccm.202101-0218ED.

Acute Respiratory Distress Syndrome Subphenotypes beyond the Syndrome: A Step toward Treatable Traits?

Kiran Reddy  1   2 , Carolyn S Calfee  3   4 , Danny F McAuley  5   6
Affiliations
Editorial

Acute Respiratory Distress Syndrome Subphenotypes beyond the Syndrome: A Step toward Treatable Traits?

Kiran Reddy et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The impending transformation in critical care syndrome classification. In the old paradigm, we classify syndromes such as respiratory failure, acute respiratory distress syndrome, and sepsis based on clinical criteria that poorly inform treatments. In the future paradigm, we identify more biologically meaningful subgroup characteristics that inform disease-modifying treatment options (treatable traits). As pictured above, the data presented by Heijnen and colleagues (10) in this issue of the Journal brings us closer to identifying treatable traits. ARDS = acute respiratory distress syndrome.
See this image and copyright information in PMC

Comment on

References

    1. Santacruz CA, Pereira AJ, Celis E, Vincent JL. Which multicenter randomized controlled trials in critical care medicine have shown reduced mortality? A systematic review. Crit Care Med. 2019;47:1680–1691. - PubMed
    1. Calfee CS, Delucchi K, Parsons PE, Thompson BT, Ware LB, Matthay MA, NHLBI ARDS Network. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med. 2014;2:611–620. - PMC - PubMed
    1. Bos LD, Schouten LR, van Vught LA, Wiewel MA, Ong DSY, Cremer O, et al. MARS consortium. Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis. Thorax. 2017;72:876–883. - PMC - PubMed
    1. Famous KR, Delucchi K, Ware LB, Kangelaris KN, Liu KD, Thompson BT, et al. Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med. 2017;195:331–338. - PMC - PubMed
    1. Calfee CS, Delucchi KL, Sinha P, Matthay MA, Hackett J, Shankar-Hari M, et al. Irish Critical Care Trials Group. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial. Lancet Respir Med. 2018;6:691–698. - PMC - PubMed

LinkOut - more resources